OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. (March 2023) - Sacco, R.; Ciruolo, M.; Paolillo, R.; Ramai, D.; Tortora, R.; Di, Costanzo G.G.; Burlone, M.; Pirisi, M.; Federico, P.; Daniele, B.; Silletta, M.; Gallo, P.; et al.